No End In Sight: FDA Postpones Another In-Person Meeting Due To COVID-19

The US agency had planned to hold an in-person meeting of its ophthalmic advisory committee in early June, indicating hope that things would be back to some form of normal by then. But due to the ongoing coronavirus pandemic, it has postponed that meeting until further notice.